InMode to Present at Upcoming Investor Conferences and Events
Get Alerts INMD Hot Sheet
Join SI Premium – FREE
YOKNEAM,

Jefferies London Healthcare Conference
Presenters:
Format: In-person fireside chat moderated by
Location:
When: Tuesday, Nov. 14 at
A live webcast of the presentation can be accessed here.
Canaccord MTDF Investor Conference
Presenters:
Format: In-person one-on-one meetings
Location:
When: Thursday, Nov. 16
Mizuho Medical Device and Healthcare Services Summit 2023
Presenters:
Format: In-person one-on-one meetings
Location:
When: Wednesday, Dec. 6
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Investor Relations Contact:
MS-IR LLC
[email protected]
917-607-8654
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-upcoming-investor-conferences-and-events-301977623.html
SOURCE InMode Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MNA: Brigham Nurse Solidarity Walk-In to Mark Lockout End Monday Morning; MGB Home Care End-of-Strike Rally Tuesday
- Concord Technologies Releases New Report on AI-Driven Interoperability and Operational Efficiency
- Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Jefferies & Co, MizuhoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share